KU59403

KU59403 Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Chengdu Peter-like Biotechnology Co., Ltd.  
Tel: 18108052721
Email: 2850505130@qq.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com

KU59403 manufacturers

  • KU 59403
  • KU 59403 pictures
  • $733.00
  • 2026-07-15
  • CAS:845932-30-1
  • Purity: 99.79%
  • Supply Ability: 10g
KU59403 Basic information
Product Name:KU59403
Synonyms:KU59403;3-(4-methylpiperazin-1-yl)-N-[6-(6-morpholin-4-yl-4-oxopyran-2-yl)thianthren-2-yl]propanamide;1-Piperazinepropanamide, 4-methyl-N-[6-[6-(4-morpholinyl)-4-oxo-4H-pyran-2-yl]-2-thianthrenyl]-;3-(4-methylpiperazin-1-yl)-N-(6-(6-morpholino-4-oxo-4H-pyran-2-yl)thianthren-2-yl)propanamide
CAS:845932-30-1
MF:C29H32N4O4S2
MW:564.72
EINECS:
Product Categories:
Mol File:845932-30-1.mol
KU59403 Structure
KU59403 Chemical Properties
Boiling point 814.3±65.0 °C(Predicted)
density 1.368±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka13.73±0.20(Predicted)
form Solid
color White to yellow
Safety Information
MSDS Information
KU59403 Usage And Synthesis
UsesKU 59403 is an Ataxia telangiectasia mutated inhibitor (ATM inhibitor) in models of human cancer.
in vivo

KU59403 with a single daily dose of 12.5 mg/kg causes a significant sensitization[1].
Increasing the dose of KU59403 to 25 mg/kg given twice daily results in the greatest chemo-sensitisation with a 3-fold increase in BMY-40481-induced tumour growth delay in both SW620 and HCT116-N7 xenografts, in the absence of a significantly increased toxicity[1].

Animal Model:CD-1 nude mice implanted with SW620 or HCT116-N7 human cancer cell lines at 1×107 cells per animal s.c. (n=5 per group)[1].
Dosage:6, 12.5 and 25 mg/kg.
Administration:I.P. twice daily (0 and 4 hours) and 12.5 mg/kg once daily.
Result:Treatment with BMY-40481 alone causes a modest tumour growth delay of 4 days (time to RTV4=10.5 days). This delay is extended to 8.5 days when given with KU 59403 at 12.5 mg/kg i.p. twice daily for 5 days and 11.5 days (time to RTV4=18 days) when given with KU 59403 at 25 mg/kg i.p. twice daily for 5 days.
KU59403 Preparation Products And Raw materials
Tag:KU59403(845932-30-1) Related Product Information
KU59403 KU 60019 KU-55933 Anti-Aging Compound Library 2,2-Diphenyl-N-(2,2,2-trichloro-1-[3-(4-fluoro-3-nitrophenyl)thioureido]ethyl)acetamide Anti-cancer compound library